Paloma Fernandez-Narros
Madrid, MD 28006, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4.
Journal: Antioxidants (Basel, Switzerland)
Published: July 03, 2023
Synthesis and Pharmacological Evaluation of New N-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout.
Journal: Journal of medicinal chemistry
Published: April 11, 2022
Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation.
Journal: Journal of medicinal chemistry
Published: February 09, 2021
Time-dependent dual effect of NLRP3 inflammasome in brain ischaemia.
Journal: British journal of pharmacology
Published: December 18, 2020
Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux.
Journal: Antioxidants (Basel, Switzerland)
Published: November 26, 2020
TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury.
Journal: British journal of pharmacology
Published: May 20, 2020
Early toll-like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro-inflammatory phenotype in rodent and human brain ischaemia models.
Journal: British journal of pharmacology
Published: July 06, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026